Infinite Roots Acquires Bosque Foods to Move Mycelium Meat Beyond the Lab

Hamburg-based biotech Infinite Roots has acquired Berlin competitor Bosque Foods, a deal that signals a maturing mycelium industry consolidating for scale. Both companies engineer meat alternatives from fungal mycelium—the underground root network of edible mushrooms. But after years of experimentation, the sector now demands more than lab results. Infinite Roots framed the acquisition explicitly around scalability, IP, process data, and industrial reproducibility .

Bosque Foods had filed for insolvency in autumn 2024, partly due to the same EU Novel Food regulatory hurdles facing many alt-protein startups . For Infinite Roots, the acquisition wasn’t just opportunistic—it filled specific technical gaps that are critical for the next phase of mycelium food production.

What Bosque Foods Brings to Infinite Roots

The merger combines two distinct fermentation disciplines and expands the product formats Infinite Roots can pursue commercially.

1. A Second Fermentation Method: Solid-State

Infinite Roots built its platform on submerged fermentation, where mycelium grows in a liquid nutrient medium. Bosque Foods, by contrast, specializes in solid-state fermentation, a different technique better suited to certain textures and product formats . Integrating both methods into a single platform strengthens the company’s technical versatility and creates a wider moat in process know-how.

2. Whole-Cut Product Capability

Bosque Foods focused on creating whole-cut meat analogues—steaks, fillets, and structured cuts that go beyond the mince-based patties and balls Infinite Roots already sells under its MushRoots brand . Whole-cut formats are technically harder to achieve with mycelium, and owning that product development pipeline now lets Infinite Roots address a higher-value segment of the alternative-protein market.

3. Proprietary Process Data and IP Density

The acquisition also transfers Bosque Foods’ proprietary datasets and fermentation IP. Infinite Roots has stated that merging complementary mycelium technologies and datasets enables faster scaling across more product formats. CEO Dr. Mazen Rizk described the sector’s next phase as one where companies must integrate biology, process data, intellectual property, and industrial implementation—a capability the combined entity is now better positioned to deliver .

Why This Deal Happened Now

The acquisition follows Infinite Roots’ record-breaking $58 million Series B funding round—reported as Europe’s largest investment in mycelium . That capital was earmarked for scaling production and launching products globally . By bringing Bosque Foods’ technology in-house at a moment when the Berlin startup was distressed, Infinite Roots appears to have moved quickly to acquire specialist process knowledge and whole-cut capabilities that would otherwise take years and significant capital to build independently.

EU Novel Food regulations remain a gating factor for mycelium-based products in Europe . Merging technology platforms under one roof may help Infinite Roots concentrate regulatory resources, share safety and process data more efficiently, and advance approvals alongside industrial scale-up.

What the Deal Signals for the Mycelium Sector

The acquisition suggests the mycelium foodtech market is shifting from a discovery phase to a consolidation phase, where companies with capital, robust IP portfolios, and industrial-ready platforms absorb earlier-stage competitors whose value lies in specialized know-how rather than standalone commercial viability.

Infinite Roots now claims over 18,000 strains in its proprietary culture collection and operates with 71 employees from its Hamburg headquarters . Adding Bosque Foods’ solid-state expertise and whole-cut pipeline puts it closer to functioning as an integrated mycelium platform company rather than a single-technology biotech startup.